Dexmedetomidine at a concentration of either5 or 10 μg/kg could inhibit the expression of TLR4 and MyD88, and the activation of ERK1/2 and NF-κB in CLP-induced sepsis. The gene discussed is MYD88; the disease is Sepsis.